Replies to post #137669 on Biotech Values

[DewDiligence]

Yet another quiz*: EXAS’ ‘Deep-C’ study testing the Cologuard diagnostic for colorectal cancer has a patent-eligibility age range of 50-84 years; why are most of the patients enrolled to date near the lower bound of this range?

*Perhaps PGS should take the day off :- )

[jellybean]

That i didn't look at the others, and now I have looked at this one?

Seriously, this is the first trial run post-approval?